On Chip Bioelectric Impedance Spectroscopy Reveals the Effect of P-Glycoprotein Efflux Pumps on the Paracellular Impedance of Tight Junctions at the Blood-Brain Barrier

被引:7
作者
Kraya, Ramsey [1 ,2 ]
Komin, Alexander [2 ,3 ]
Searson, Peter [2 ,3 ]
机构
[1] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Inst Nanobiotechnol, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA
基金
美国国家卫生研究院;
关键词
Bioimpedance; cells (biology); drug delivery; TYROSINE PHOSPHATASE INHIBITION; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; TUMOR-CELLS; OCCLUDIN; PHOSPHORYLATION; PERMEABILITY; TRANSPORT; PATHWAYS; BILAYERS;
D O I
10.1109/TNB.2016.2604322
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Bioelectric impedance spectroscopy was used to elucidate the influence of P-gp efflux pumps on the kinetics of tight junction down-regulation in confluent monolayers of Madine Darby Canine Kidney Epithelial Cells (MDCK) following administration of phenylarsine oxide (PAO), a molecule that inhibits protein tyrosine phosphatases (PTP) and induces matrix metalloproteinase activity. Matrix metalloproteinases (MMPs) and phosphatase inhibitors induce modification of occludin tight junction proteins critical for the proper function of the blood-brain barrier. The addition of PAO to MDCKII cell lines resulted in a dramatic decrease in monolayer resistance. In contrast, MDCKII-MDR1 cells transfected with the MDR1 gene treated with PAO showed an initial decrease in monolayer resistance followed by a partial recovery and subsequent decrease. This resistance decay reversal was suppressed with the addition of the P-glycoprotein (P-gp) pump inhibitor elacridar, and is attributed to PAO efflux. These results illustrate impedance spectroscopy can be used to characterize the competing kinetics of efflux and down-regulation of tight junctions. In addition, the resistance decay reversal effect can be used to evaluate P-gp pump inhibitor efficacy.
引用
收藏
页码:697 / 703
页数:7
相关论文
共 50 条
[31]   Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET [J].
Syvanen, Stina ;
Blomquist, Gunnar ;
Sprycha, Margareta ;
Hoglund, A. Urban ;
Roman, Magnus ;
Eriksson, Olof ;
Hammarlund-Udenaes, Margareta ;
Langstrom, Bengt ;
Bergstrom, Mats .
NEUROIMAGE, 2006, 32 (03) :1134-1141
[32]   Inhibitory Effects of Furanocoumarin Derivatives in Kampo Extract Medicines on P-Glycoprotein at the Blood-Brain Barrier [J].
Iwanaga, Kazunori ;
Yoneda, Shinji ;
Hamahata, Yukimi ;
Miyazaki, Makoto ;
Shibano, Makio ;
Taniguchi, Masahiko ;
Baba, Kimiye ;
Kakemi, Masawo .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (08) :1246-1251
[33]   Impact of P-Glycoprotein Inhibition and Lipopolysaccharide Administration on Blood-Brain Barrier Transport of Colistin in Mice [J].
Jin, Liang ;
Li, Jian ;
Nation, Roger L. ;
Nicolazzo, Joseph A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (02) :502-507
[34]   Activation of PKC isoform βI at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain [J].
Rigor, Robert R. ;
Hawkins, Brian T. ;
Miller, David S. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2010, 30 (07) :1373-1383
[35]   TGF-β1 Regulation of Multidrug Resistance P-glycoprotein in the Developing Male Blood-Brain Barrier [J].
Baello, Stephanie ;
Iqbal, Majid ;
Bloise, Enrrico ;
Javam, Mohsen ;
Gibb, William ;
Matthews, Stephen G. .
ENDOCRINOLOGY, 2014, 155 (02) :475-484
[36]   Regional P-Glycoprotein Activity and Inhibition at the Human Blood-Brain Barrier as Imaged by Positron Emission Tomography [J].
Eyal, S. ;
Ke, B. ;
Muzi, M. ;
Link, J. M. ;
Mankoff, D. A. ;
Collier, A. C. ;
Unadkat, J. D. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (05) :579-585
[37]   Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles [J].
Aryal, Muna ;
Fischer, Krisztina ;
Gentile, Caroline ;
Gitto, Salvatore ;
Zhang, Yong-Zhi ;
McDannold, Nathan .
PLOS ONE, 2017, 12 (01)
[38]   P-glycoprotein activity in the blood-brain barrier is affected by virus-induced neuroinflammation and antipsychotic treatment [J].
Doorduin, Janine ;
de Vries, Erik F. J. ;
Dierckx, Rudi A. ;
Klein, Hans C. .
NEUROPHARMACOLOGY, 2014, 85 :548-553
[39]   Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? [J].
Abdullahi, Wazir ;
Davis, Thomas P. ;
Ronaldson, Patrick T. .
AAPS JOURNAL, 2017, 19 (04) :931-939
[40]   Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain [J].
Cannon, Ronald E. ;
Peart, John C. ;
Hawkins, Brian T. ;
Campos, Christopher R. ;
Miller, David S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (39) :15930-15935